THC Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
5.6B
+0.1%
5.6B
-2.6%
5.8B
+8.1%
5.3B
+1.1%
5.3B
Cost of Revenue
0
0
0
0
0
Gross Profit
5.6B
+0.1%
5.6B
-2.6%
5.8B
+8.1%
5.3B
+1.1%
5.3B
Operating Expenses
4.6B
+8.9%
4.2B
-6.9%
4.5B
-4.6%
4.8B
+6.1%
4.5B
R&D
0
0
0
0
0
SG&A
2.2B
-2.6%
2.2B
+2.6%
2.2B
-2.2%
2.2B
+0.8%
2.2B
Operating Income
1.0B
-26.5%
1.4B
+12.8%
1.2B
+110.8%
590.0M
-26.7%
805.0M
EBITDA
1.3B
+4.2%
1.2B
-18.7%
1.5B
+66.6%
915.0M
-11.6%
1.0B
Net Income
1.2B
+16.7%
1.0B
+15.3%
906.0M
+40.7%
644.0M
+11.2%
579.0M
EPS (Basic)
$12.48
+26.2%
$9.89
+22.2%
$8.09
+90.4%
$4.25
+9.3%
$3.89
EPS (Diluted)
$12.41
+26.1%
$9.84
+22.8%
$8.01
+89.8%
$4.22
+9.3%
$3.86
Shares (Diluted)
80.6M
-4.0%
84.0M
-4.1%
87.6M
-0.4%
87.9M
-0.8%
88.6M
Tenet Healthcare Corporation New (THC) — Financials